| RS2527260044 |
NLRP3
|
Health Risk |
Pathogenic |
Cryopyrin associated periodic syndrome, Cryopyrin associated periodic syndrome |
| RS2527260934 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527261243 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS2527268786 |
NLRP3
|
Health Risk |
Likely pathogenic |
— |
| RS2527269566 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527270896 |
TNFRSF9
|
Health Risk |
Pathogenic |
— |
| RS2527270913 |
TNFRSF9
|
Health Risk |
Pathogenic |
— |
| RS2527272194 |
TNFRSF9
|
Health Risk |
Pathogenic |
— |
| RS2527274077 |
NLRP3
|
Health Risk |
Likely pathogenic |
Familial amyloid nephropathy with urticaria AND deafness, Familial amyloid nephropathy with urticaria AND deafness |
| RS2527280678 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2527280793 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2527280897 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2527280954 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2527281026 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2527281261 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2527281270 |
CDC73
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2527281408 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2527281416 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2527281543 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Parathyroid carcinoma |
| RS2527284830 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527285147 |
LYST
|
Health Risk |
Pathogenic |
LYST-related disorder, LYST-related disorder |
| RS2527285195 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527285556 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527287298 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS2527288755 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527289295 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527289344 |
CDC73
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527295379 |
ASPM
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2527295538 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS2527295551 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS2527295914 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527296137 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527298688 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS2527299440 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527299680 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527299998 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2527300997 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527301436 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527301480 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527303681 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS2527304656 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527305337 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS2527306042 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2527307212 |
ASPM
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2527308315 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527308382 |
FH
|
Health Risk |
Likely pathogenic |
Fumarase deficiency, Fumarase deficiency |
| RS2527308386 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527308398 |
FH
|
Health Risk |
Pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS2527308441 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527308465 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527308484 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527308519 |
FH
|
Health Risk |
Pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS2527308607 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527311881 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2527312860 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527313001 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527313025 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527313050 |
FH
|
Health Risk |
Likely pathogenic |
Fumarase deficiency, Fumarase deficiency |
| RS2527313091 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527313129 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527313198 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS2527313228 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527316352 |
CACNA1E
|
Health Risk |
Likely pathogenic |
— |
| RS2527316484 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS2527316491 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527316654 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527316660 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527316690 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527316769 |
FH
|
Health Risk |
Pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary cancer-predisposing syndrome |
| RS2527317342 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperparathyroidism 1, Parathyroid carcinoma |
| RS2527317468 |
CDC73
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527319019 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527319050 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527319143 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527319221 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS2527319345 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527319402 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527319424 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527319443 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527319645 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS2527319648 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527319705 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527319814 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS2527322667 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527322866 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Fumarase deficiency, Hereditary cancer-predisposing syndrome |
| RS2527323022 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527323113 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527323181 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527324049 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527324275 |
CDC73
|
Health Risk |
Pathogenic |
Hyperparathyroidism 1, Hyperparathyroidism 1 |
| RS2527324301 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2527324463 |
CDC73
|
Health Risk |
Likely pathogenic |
Hyperparathyroidism 2 with jaw tumors, Hyperparathyroidism 2 with jaw tumors |
| RS2527324489 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527324515 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527324739 |
CDC73
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hyperparathyroidism 1 |
| RS2527324879 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS2527327079 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527327168 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2527327324 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2527327485 |
FH
|
Health Risk |
Pathogenic |
— |